Cancer Epigenetics: An Overview
Cancer is a complex disease caused by genetic and epigenetic alterations in the control of cell division. Findings from the field of cancer genomics and epigenomics have increased our understanding of the origin and evolution of tumorigenic processes, greatly advancing our knowledge of the molecular...
Gespeichert in:
Veröffentlicht in: | Archives of medical research 2022-12, Vol.53 (8), p.732-740 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 740 |
---|---|
container_issue | 8 |
container_start_page | 732 |
container_title | Archives of medical research |
container_volume | 53 |
creator | Recillas-Targa, Félix |
description | Cancer is a complex disease caused by genetic and epigenetic alterations in the control of cell division. Findings from the field of cancer genomics and epigenomics have increased our understanding of the origin and evolution of tumorigenic processes, greatly advancing our knowledge of the molecular etiology of cancer. Consequently, any contemporary view of cancer research must consider tumorigenesis as a cellular phenomenon that is a result of the interplay between genetic and epigenetic mutations and their interaction with environmental factors, including our microbiome, that influences cellular metabolism and proliferation rates. The integration and better knowledge of these processes will help us to improve diagnosis, prognosis, and future genetic and epigenetic therapies. Here, I present an overview of the epigenetic processes that are affected in cancer and how they contribute to the onset and progression of the disease. Finally, I discuss how the development of sophisticated experimental approaches and computational tools, including novel ways to exploit large data sets, could contribute to the better understanding and treatment of cancer. |
doi_str_mv | 10.1016/j.arcmed.2022.11.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2739069089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0188440922001424</els_id><sourcerecordid>2739069089</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-c74828ff2937250fe1c108d0f0774e7bd688813406ea14c755b50121338bb6d3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqHwDxB0ZEm4s53YYUCqqvIhVerS3UqcC3LVJsVOi_j3pEq7Mt1wz3uv7mHsHiFBwOx5nRTebqlKOHCeICYA4oJFqJWIU6nVJYsAtY6lhHzEbkJYA4CWmbpmI5FJRFQiYo-zorHkJ_Od-6KGOmfDy2TaTJYH8gdHP7fsqi42ge5Oc8xWb_PV7CNeLN8_Z9NFbIXCLrZKaq7rmudC8RRqQougK6hBKUmqrDKtNQoJGRUorUrTMgXkKIQuy6wSY_Y0nN359ntPoTNbFyxtNkVD7T4YrkQOWQ4671E5oNa3IXiqzc67beF_DYI5mjFrM5gxRzMG0fRm-tjDqWFfHnfn0FlFD7wOAPVv9q97E6yjXk7lPNnOVK37v-EPpF5yyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2739069089</pqid></control><display><type>article</type><title>Cancer Epigenetics: An Overview</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Recillas-Targa, Félix</creator><creatorcontrib>Recillas-Targa, Félix</creatorcontrib><description>Cancer is a complex disease caused by genetic and epigenetic alterations in the control of cell division. Findings from the field of cancer genomics and epigenomics have increased our understanding of the origin and evolution of tumorigenic processes, greatly advancing our knowledge of the molecular etiology of cancer. Consequently, any contemporary view of cancer research must consider tumorigenesis as a cellular phenomenon that is a result of the interplay between genetic and epigenetic mutations and their interaction with environmental factors, including our microbiome, that influences cellular metabolism and proliferation rates. The integration and better knowledge of these processes will help us to improve diagnosis, prognosis, and future genetic and epigenetic therapies. Here, I present an overview of the epigenetic processes that are affected in cancer and how they contribute to the onset and progression of the disease. Finally, I discuss how the development of sophisticated experimental approaches and computational tools, including novel ways to exploit large data sets, could contribute to the better understanding and treatment of cancer.</description><identifier>ISSN: 0188-4409</identifier><identifier>EISSN: 1873-5487</identifier><identifier>DOI: 10.1016/j.arcmed.2022.11.003</identifier><identifier>PMID: 36411173</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bioinformatics ; Cancer ; Chromatin ; DNA Methylation ; Epigenesis, Genetic ; Epigenetics ; Epigenomics ; Genomics ; Humans ; Metabolism ; Microbiome ; Neoplasms - genetics ; Neoplasms - therapy</subject><ispartof>Archives of medical research, 2022-12, Vol.53 (8), p.732-740</ispartof><rights>2022 Instituto Mexicano del Seguro Social (IMSS)</rights><rights>Copyright © 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-c74828ff2937250fe1c108d0f0774e7bd688813406ea14c755b50121338bb6d3</citedby><cites>FETCH-LOGICAL-c371t-c74828ff2937250fe1c108d0f0774e7bd688813406ea14c755b50121338bb6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36411173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Recillas-Targa, Félix</creatorcontrib><title>Cancer Epigenetics: An Overview</title><title>Archives of medical research</title><addtitle>Arch Med Res</addtitle><description>Cancer is a complex disease caused by genetic and epigenetic alterations in the control of cell division. Findings from the field of cancer genomics and epigenomics have increased our understanding of the origin and evolution of tumorigenic processes, greatly advancing our knowledge of the molecular etiology of cancer. Consequently, any contemporary view of cancer research must consider tumorigenesis as a cellular phenomenon that is a result of the interplay between genetic and epigenetic mutations and their interaction with environmental factors, including our microbiome, that influences cellular metabolism and proliferation rates. The integration and better knowledge of these processes will help us to improve diagnosis, prognosis, and future genetic and epigenetic therapies. Here, I present an overview of the epigenetic processes that are affected in cancer and how they contribute to the onset and progression of the disease. Finally, I discuss how the development of sophisticated experimental approaches and computational tools, including novel ways to exploit large data sets, could contribute to the better understanding and treatment of cancer.</description><subject>Bioinformatics</subject><subject>Cancer</subject><subject>Chromatin</subject><subject>DNA Methylation</subject><subject>Epigenesis, Genetic</subject><subject>Epigenetics</subject><subject>Epigenomics</subject><subject>Genomics</subject><subject>Humans</subject><subject>Metabolism</subject><subject>Microbiome</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - therapy</subject><issn>0188-4409</issn><issn>1873-5487</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqHwDxB0ZEm4s53YYUCqqvIhVerS3UqcC3LVJsVOi_j3pEq7Mt1wz3uv7mHsHiFBwOx5nRTebqlKOHCeICYA4oJFqJWIU6nVJYsAtY6lhHzEbkJYA4CWmbpmI5FJRFQiYo-zorHkJ_Od-6KGOmfDy2TaTJYH8gdHP7fsqi42ge5Oc8xWb_PV7CNeLN8_Z9NFbIXCLrZKaq7rmudC8RRqQougK6hBKUmqrDKtNQoJGRUorUrTMgXkKIQuy6wSY_Y0nN359ntPoTNbFyxtNkVD7T4YrkQOWQ4671E5oNa3IXiqzc67beF_DYI5mjFrM5gxRzMG0fRm-tjDqWFfHnfn0FlFD7wOAPVv9q97E6yjXk7lPNnOVK37v-EPpF5yyQ</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Recillas-Targa, Félix</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202212</creationdate><title>Cancer Epigenetics: An Overview</title><author>Recillas-Targa, Félix</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-c74828ff2937250fe1c108d0f0774e7bd688813406ea14c755b50121338bb6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bioinformatics</topic><topic>Cancer</topic><topic>Chromatin</topic><topic>DNA Methylation</topic><topic>Epigenesis, Genetic</topic><topic>Epigenetics</topic><topic>Epigenomics</topic><topic>Genomics</topic><topic>Humans</topic><topic>Metabolism</topic><topic>Microbiome</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Recillas-Targa, Félix</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Recillas-Targa, Félix</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer Epigenetics: An Overview</atitle><jtitle>Archives of medical research</jtitle><addtitle>Arch Med Res</addtitle><date>2022-12</date><risdate>2022</risdate><volume>53</volume><issue>8</issue><spage>732</spage><epage>740</epage><pages>732-740</pages><issn>0188-4409</issn><eissn>1873-5487</eissn><abstract>Cancer is a complex disease caused by genetic and epigenetic alterations in the control of cell division. Findings from the field of cancer genomics and epigenomics have increased our understanding of the origin and evolution of tumorigenic processes, greatly advancing our knowledge of the molecular etiology of cancer. Consequently, any contemporary view of cancer research must consider tumorigenesis as a cellular phenomenon that is a result of the interplay between genetic and epigenetic mutations and their interaction with environmental factors, including our microbiome, that influences cellular metabolism and proliferation rates. The integration and better knowledge of these processes will help us to improve diagnosis, prognosis, and future genetic and epigenetic therapies. Here, I present an overview of the epigenetic processes that are affected in cancer and how they contribute to the onset and progression of the disease. Finally, I discuss how the development of sophisticated experimental approaches and computational tools, including novel ways to exploit large data sets, could contribute to the better understanding and treatment of cancer.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36411173</pmid><doi>10.1016/j.arcmed.2022.11.003</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0188-4409 |
ispartof | Archives of medical research, 2022-12, Vol.53 (8), p.732-740 |
issn | 0188-4409 1873-5487 |
language | eng |
recordid | cdi_proquest_miscellaneous_2739069089 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Bioinformatics Cancer Chromatin DNA Methylation Epigenesis, Genetic Epigenetics Epigenomics Genomics Humans Metabolism Microbiome Neoplasms - genetics Neoplasms - therapy |
title | Cancer Epigenetics: An Overview |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A31%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20Epigenetics:%20An%20Overview&rft.jtitle=Archives%20of%20medical%20research&rft.au=Recillas-Targa,%20F%C3%A9lix&rft.date=2022-12&rft.volume=53&rft.issue=8&rft.spage=732&rft.epage=740&rft.pages=732-740&rft.issn=0188-4409&rft.eissn=1873-5487&rft_id=info:doi/10.1016/j.arcmed.2022.11.003&rft_dat=%3Cproquest_cross%3E2739069089%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2739069089&rft_id=info:pmid/36411173&rft_els_id=S0188440922001424&rfr_iscdi=true |